A carregar...
Evaluation of intravenous voriconazole in patients with compromised renal function
BACKGROUND: Incorporation of the solubilizing excipient, sulfobutylether-β-cyclodextrin (SBECD), in the intravenous (IV) formulation of voriconazole has resulted in the recommendation that this formulation be used with caution in patients with creatinine clearances (Cl(cr)) < 50 mL/min. This stud...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3584958/ https://ncbi.nlm.nih.gov/pubmed/23320795 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2334-13-14 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|